Serious infection incidence rates in pediatric systemic lupus erythematosus according to medication use

Linda T. Hiraki(Harvard University), Karen H. Costenbader(Brigham and Women's Hospital), Wolfgang C. Winkelmayer­(Palo Alto University), Michael A. Fischer(Adobe Systems (United States)), Daniel H. Solomon(Brigham and Women's Hospital), Candace H. Feldman(Brigham and Women's Hospital), Jessica M. Franklin(New England College of Optometry), Seoyoung C. Kim(Kookmin University), Mary Beth F. Son(Boston Children's Hospital)
Arthritis Research & Therapy
January 1, 2014
10.1186/ar4655
Cited by 0

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts
|PLoS Medicine|2013|1.1k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
|American Journal of Kidney Diseases|2021|727